- Home
- CSAI vs OBIO Comparison
CSAI vs OBIO Comparison
Compare CSAI & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSAI
- OBIO
- Stock Information
- Founded
- CSAI N/A
- OBIO 2017
- Country
- CSAI
- OBIO United States
- Employees
- CSAI N/A
- OBIO N/A
- Industry
- CSAI
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- CSAI
- OBIO Health Care
- Exchange
- CSAI NYSE
- OBIO Nasdaq
- Market Cap
- CSAI N/A
- OBIO 151.3M
- IPO Year
- CSAI N/A
- OBIO N/A
- Fundamental
- Price
- CSAI $4.92
- OBIO $4.40
- Analyst Decision
- CSAI
- OBIO Strong Buy
- Analyst Count
- CSAI 0
- OBIO 5
- Target Price
- CSAI N/A
- OBIO $15.40
- AVG Volume (30 Days)
- CSAI N/A
- OBIO 55.1K
- Earning Date
- CSAI N/A
- OBIO 05-12-2025
- Dividend Yield
- CSAI N/A
- OBIO N/A
- EPS Growth
- CSAI N/A
- OBIO N/A
- EPS
- CSAI N/A
- OBIO N/A
- Revenue
- CSAI N/A
- OBIO $2,647,000.00
- Revenue This Year
- CSAI N/A
- OBIO $22.61
- Revenue Next Year
- CSAI N/A
- OBIO $16.64
- P/E Ratio
- CSAI N/A
- OBIO N/A
- Revenue Growth
- CSAI N/A
- OBIO N/A
- 52 Week Low
- CSAI N/A
- OBIO $3.75
- 52 Week High
- CSAI N/A
- OBIO $8.87
- Technical
- Relative Strength Index (RSI)
- CSAI N/A
- OBIO 47.67
- Support Level
- CSAI N/A
- OBIO $4.14
- Resistance Level
- CSAI N/A
- OBIO $4.64
- Average True Range (ATR)
- CSAI 0.00
- OBIO 0.32
- MACD
- CSAI 0.00
- OBIO 0.08
- Stochastic Oscillator
- CSAI 0.00
- OBIO 63.39
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.